About this trial
The purpose of this study is to evaluate body composition across a variety of medical, professional, and commercial devices, including: bioelectrical impedance analysis (BIA) devices, 3-dimensional optical imaging (3DO), manual anthropometry measurements, dual-energy X-ray absorptiometry (DXA), magnetic resonance imaging (MRI), and blood tests. The secondary study purpose is to compare body composition measurements from BIA devices, 3DO, and manual anthropometry measurements within a 1-week period for a subset of the study population.
The study plans to enroll 300 healthy (having no life-threatening conditions or diseases; male and female) participants, 18 years of age or older.
Eligibility criteria
Qualifiers
Being willing to provide written informed consent prior to participation Being willing to complete the study visits and comply with the study procedures
Being willing to travel to the various study locations for On-site, DXA, MRI, and Phlebotomy visits
Being willing to change into appropriate form-fitting clothing for 3DO assessments and/or appropriate gowns for DXA and MRI imaging
Must have a BMI within the range of 18.5 - 45 kg/m2
Disqualifiers
Being pregnant or attempting to become pregnant
Having medical implants, such as a pacemaker or metal joint replacements, or other metal implants contraindicated for MRI
Cosmetic implants, such as breast implants
Having a height greater than DXA scanning limit (77 inches)
Trial design
Treatments tested in this trial
- Not listed
Trial groups
Sponsors and collaborators
Foundation for the National Institutes of Health
Lead sponsor
Exponent, Inc.
Collaborator
Pennington Biomedical Research Center
Collaborator
Texas Tech University
Collaborator